PARTNER IJoe Segen2016-11-29T15:55:41+00:00
Definition A study which asked if transcatheter aortic valve replacement—TAVR in patients with severe, inoperable aortic stenosis yielded a sustained mortality benefit, improved functional status and a decreased rate of rehospitalization vs. standard therapy*.
*Which frequently consisted of balloon valvuloplasty
Conclusion Yes. 5-year all-cause mortality was 94% with standard therapy and 72% in the TAVR group (P<.0001). The standard therapy group had a median survival of 11 months vs. 29 months in the TAVR group (P<.001).